Asthma and tobacco;Asthme et tabac

Revue Medicale de Liege

Volumn 61, Issue 2, 2006, Pages 81-86

  Gusbin, N ^a   Garzaniti, N ^a   Louis, R ^b  

^a Centre Hospitalier Hutois   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Asthma; Corticoids resistance; Tobacco

Indexed keywords

CILOMILAST; CORTICOSTEROID; DNA; HISTONE DEACETYLASE; INTERLEUKIN 2; INTERLEUKIN 8; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PHOSPHODIESTERASE IV INHIBITOR; THEOPHYLLINE; TUMOR NECROSIS FACTOR;

ARTICLE; ASTHMA; CELL TYPE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; INFLAMMATION; OXIDATIVE STRESS; PHENOTYPE; RISK FACTOR; SMOKING; SMOKING CESSATION; TOBACCO;

ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; DRUG RESISTANCE; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 33644752766     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Piipari R, Jaakola JJK, Jaakola N.- Smoking and asthma in adults. Eur Respir J, 2004, 24, 734-739.
2. Thomson NC, Chaudhuri R, Livingston E.- Asthma and cigarette smoking. Eur Respir J, 2004, 24, 822-833.
3. Haahtela T, Klaukka T, Koskela K et al.- Asthma programme in Finland: a community problem needs community solutions. Thorax, 2001, 56, 806-814.
4. Sandström T, Lundbäck B.- Tobacco smoke: old foe more important for asthma than commonly appreciated? Eur Respir J, 2004, 24, 720-721.
5. Fabbri LM, Romagnoli M, Corbetta L et al.- Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2003, 167, 418-424.
6. Louis R, Corhay JL, Bury T et al.- L'hyperréactivité bronchique non spécifique: Données épidémiologiques et signification clinique. Rev med de Liège, 1993, 58, 213-219.
7. Ramdsdale EH, Roberts RS, Morris MM et al.- Differences in responsiveness to hyperventilation and metacholine in asthma and chronic bronchitis. Thorax, 1985, 40, 422-426.
8. Oosterhoff Y, de Jong JW, Jansen MA et al.- Airway responsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease is determined by smoking. Am Rev Respir Dis, 1993, 147, 553-558.
9. Godtfredsen NS, Lange P, Prescott E et al.- Changes in smoking habits and risk of asthma: a longitudinal population based study. Eur Respir J, 2001, 18, 549-554.
10. Siroux V, Pin I, Oryszczyn MP et al.- Relationships of active smoking to asthma and asthma severity in the EGEA study. Eur Respir J, 2000, 15, 470-477.
11. James AL, Palmer LJ, Kicic E et al.- Decline in lung function in the Busselton Health Study. The effects of asthma and cigarette smoking. Am J Respir Crit Care Med, 2005, 111, 109-114.
12. Mitsunobu F, Ashida K, Hosaki Y et al.- Influence of long-term cigarette smoking on immunoglobulin E-mediated allergy, pulmonary function, and high-resolution computed tomography lung densitometry in elderly patients with asthma. Clin Exp Allergy, 2004, 34, 59-64.
13. Thomson NC, Chaudhuri R, Livingston E.- Active cigarette smoking and asthma. Clin Exp Allergy, 2003, 33, 1471-1475.
14. Willemse BWM, Postma DS, Timens W et al.- The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J, 2004, 23, 464-476.
15. McKay A, Komai-Koma M, MacLeod KJ, et al.- Interleukin-18 levels in induced sputum are reduced in asthmatic and normal smokers. Clin Exp Allergy, 2004, 34, 904-910.
16. Keatings VM et al.- Differences in Interleukin-8 and Tumor Necrosis Factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med, 1996, 153, 530-534.
17. Chalmers GW, MacLeod KJ, Thomson L et al.- Smoking and airway inflammation in patients with mild asthma. Chest, 2001, 120, 1917-1922.
18. McCrea KA, Ensor JE, Nall K et al.- Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med, 1994, 150, 696-703.
19. Wooley KR et al.- Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med, 1996, 154, 237-243.
20. Barnes PJ, Adcock IM.- How do corticosteroids work in asthma? Ann Intern Med, 2003, 139, 359-370.
21. Barnes PJ, Ito K, Adcock IM.- Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. The Lancet, 2004, 363, 731-733.
22. Chalmers GW, MacLeod KJ, Little SA et al- Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax, 2002, 57, 226-230.
23. Chaudhuri R, Livingston E, McMahon AD et al.- Cigarette smoking impairs the therapeutic response to oral corticosteroid in chronic asthma. Am J Respir Crit Care Med, 2003, 168, 1308-1311.
24. Bel EH.- A neglected cause of glucocorticoid resistance in asthma. Am J Crit Care Med, 2003, 168, 1265-1266.
25. Tomlinson JEM, McMahon AD, Chaudhuri R et al.- Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax, 2005, 60, 282-287.
26. Green RH, Brightling CE, Woltmann G et al.- Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax, 2002, 57, 875-879.
27. Webster JC, Oakley RH, Jewell CM et al.- Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: A mechanism for the generation of glucocorticoid resistance. PNAS, 2001, 98, 6865-6870.
28. Livingston E, Darroch CE, Chaudhuri R et al.- Glucocorticoid receptor α/β ratio in blood mononuclear cells is reduced in cigarette smokers. J Allergy Clin Immunol, 2004, 114, 1475-1478.
29. Ito K, Lim S, Caramori G et al.- A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. PNAS, 2002, 99, 8921-8926.
30. Jayaram L, Pizzichini E, Lemière C et al.- Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticazone and montelukast. Thorax, 2005, 60, 100-105.
31. Simon HU, Seelbach H, Ehmann R et al.- Clinical and immunological effects of low-dose IFN-a treatment in patients with corticosteroid-resistant asthma. Allergy, 2003, 58, 1250-1255.